mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.3 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.3 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |